Z-0926-2021 Class II Terminated
FDA device recall Z-0926-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Nov 15, 2020 and is designated Class II. Reason for recall: Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function. The recall status is terminated (terminated Dec 23, 2025). Affected quantity: 2 units.
Recall details
- Product Type
- Devices
- Report Date
- Feb 3, 2021
- Initiation Date
- Nov 15, 2020
- Termination Date
- Dec 23, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 units
Product description
Medtronic COBALT HF QUAD CRT-D MRI SureScan, Model Number DTPB2QQ, MR Conditional implantable cardioverter defibrillator with cardiac resynchronization therapy, SureScan technology, and Bluetooth wireless telemetry (DDE-DDDR)
Reason for recall
Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function.
Distribution pattern
Distribution to US states of GA, PA, NJ, and France
Code information
Serial Numbers: RTK602501S, RTK602506S
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0926-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026